HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...
Herpes is an incurable virus that spreads via physical contact in the mouth or genitals. However, medication can limit ...
This is a preview. Log in through your library . Abstract Objective: The objective of this study was to estimate the prevalence and correlates of herpes simplex virus type 2 infection in women in an ...
This is a preview. Log in through your library . Abstract Background and Objectives: The genital herpes epidemic continues, in part, because patients with subclinical or atypical presentations cannot ...
Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent ...
Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...
3d
The Herpes Hope: How a Modified Virus Is Giving New Options to Patients With Untreatable Skin Cancer
A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...
The HSV testing market sees growth opportunities in advanced molecular assays, increased adoption in decentralized settings, ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback